ResearcherDüsseldorf University HospitalNo recent work listed
Alexander Rehders
Matched on ORCID iD 0000-0002-7141-0694; OpenAlex author ID A5037085413. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: 2 papers
Papers 7
- Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14143494↗
- Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. Co-author DOI 10.3390/ijerph19063731↗
- Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. Co-author DOI 10.1016/j.pan.2021.02.024↗
- Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers14010068↗
- Peridural Anesthesia and Cancer-Related Survival after Surgery for Pancreatic Cancer-A Retrospective Cohort Study. Co-author DOI 10.3390/clinpract11030070↗
- Advanced Pancreatic Adenocarcinoma: Complete Histological Response After Palliative Therapy with Gemcitabine and Cisplatin. First author DOI 10.1007/s12029-012-9380-7↗
- Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Co-author DOI 10.1016/j.surg.2012.05.012↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wolfram Trudo Knoefel · 7 shared papers, 2012–2022 · strength 0.75
- Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
- Paper Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. DOI 10.3390/ijerph19063731↗
- Paper Peridural Anesthesia and Cancer-Related Survival after Surgery for Pancreatic Cancer-A Retrospective Cohort Study. DOI 10.3390/clinpract11030070↗
- Sami Alexander Safi · 4 shared papers, 2021–2022 · strength 0.54
- Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
- Paper Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. DOI 10.3390/ijerph19063731↗
- Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
- Lena Häberle · 3 shared papers, 2021–2022 · strength 0.40
- Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
- Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
- Paper Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreat… DOI 10.3390/cancers14010068↗
- Iréne Esposito · 3 shared papers, 2021–2022 · strength 0.40
- Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
- Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
- Paper Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreat… DOI 10.3390/cancers14010068↗
- A. Alexander · 4 shared papers, 2012–2022 · strength 0.35
- Paper Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. DOI 10.3390/ijerph19063731↗
- Paper Peridural Anesthesia and Cancer-Related Survival after Surgery for Pancreatic Cancer-A Retrospective Cohort Study. DOI 10.3390/clinpract11030070↗
- Paper Advanced Pancreatic Adenocarcinoma: Complete Histological Response After Palliative Therapy with Gemcitabine and Cispla… DOI 10.1007/s12029-012-9380-7↗
- Christian Vay · 2 shared papers, 2022 · strength 0.29
- Andreas H. Krieg · 2 shared papers, 2021–2022 · strength 0.27
- Tom Luedde · 2 shared papers, 2021 · strength 0.25
- Peter Kienbaum · 1 shared paper, 2021 · strength 0.13
- Farid Ziayee · 1 shared paper, 2021 · strength 0.12
- Nikolas Hendrik Stoecklein · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.